Back

Lack of Ameliorative Effect of Chronic Oral Nicotine on Olfactory Dysfunction in Young Adult Presenilin-1/2 Double Knockout Mice of a Dementia Model

Si, Y.; Qiu, S.; Jia, J.; Duan, J.; Feng, W.; Meng, B.; Qi, F.

2024-11-14 animal behavior and cognition
10.1101/2024.11.14.623574 bioRxiv
Show abstract

Olfactory dysfunction is a prevalent and early feature of neurodegenerative diseases including Alzheimers disease while the features and underlying mechanisms remain inadequately understood. This investigation aimed to elucidate the olfactory function characteristics of presenilin-1/2 double knockout (DKO) mice, an established mouse model of dementia. Through a series of behavioral tests on DKO and wildtype (WT) mice at 2 and 6 months of age, we assessed their abilities in odor detection, discrimination, and olfactory memory. The findings revealed a substantial deficit in odor detection in 2-month-old DKO mice compared to WT mice, with a noteworthy age-related deterioration observed from 2 to 6 months. Although DKO mice exhibited normal odor discrimination and olfactory memory capabilities at 2 months, these functions declined with age, falling significantly lower levels than observed in WT mice by the age of 6 months. Subsequently, 2-month-old DKO and WT mice underwent a 4-month chronic nicotine treatment through drinking water. This intervention failed to ameliorate olfactory dysfunctions in DKO mice and exhibited no significant impact on WT mice, despite a discernible trend of a potential negative effect. In summary, this behavioral study elucidates that Presenilin-1/2 double knockout impairs odor detection in young adult mice and accelerates declines of olfactory discrimination and memory. The chronic administration of nicotine did not effectively mitigate olfactory function deficiencies in young adult DKO mice, and the results also highlight age as an important contributing factor.

Matching journals

The top 4 journals account for 50% of the predicted probability mass.

1
Journal of Alzheimer’s Disease
39 papers in training set
Top 0.1%
28.1%
2
PLOS ONE
4510 papers in training set
Top 15%
12.5%
3
Neurobiology of Aging
95 papers in training set
Top 0.4%
7.3%
4
Scientific Reports
3102 papers in training set
Top 40%
3.3%
50% of probability mass above
5
Neuroscience Letters
28 papers in training set
Top 0.1%
3.1%
6
Frontiers in Neuroscience
223 papers in training set
Top 2%
3.1%
7
Translational Psychiatry
219 papers in training set
Top 2%
3.1%
8
Behavioural Brain Research
70 papers in training set
Top 0.3%
2.8%
9
Alzheimer's & Dementia
143 papers in training set
Top 2%
2.1%
10
Biology of Sex Differences
29 papers in training set
Top 0.2%
1.9%
11
Alzheimer's & Dementia: Diagnosis, Assessment & Disease Monitoring
38 papers in training set
Top 0.6%
1.9%
12
European Journal of Neuroscience
168 papers in training set
Top 0.4%
1.7%
13
Aging
69 papers in training set
Top 1%
1.7%
14
Neurobiology of Disease
134 papers in training set
Top 3%
1.7%
15
Frontiers in Aging Neuroscience
67 papers in training set
Top 2%
1.7%
16
European Journal of Pharmacology
11 papers in training set
Top 0.1%
1.7%
17
Neuroscience Bulletin
11 papers in training set
Top 0.4%
1.4%
18
iScience
1063 papers in training set
Top 23%
1.1%
19
Biomedicine & Pharmacotherapy
43 papers in training set
Top 0.7%
1.0%
20
Biomedicines
66 papers in training set
Top 2%
1.0%
21
eLife
5422 papers in training set
Top 53%
0.9%
22
International Journal of Biological Macromolecules
65 papers in training set
Top 3%
0.9%
23
Frontiers in Pharmacology
100 papers in training set
Top 4%
0.9%
24
International Journal of Molecular Sciences
453 papers in training set
Top 14%
0.8%
25
Cells
232 papers in training set
Top 5%
0.8%
26
eneuro
389 papers in training set
Top 9%
0.8%
27
Biology
43 papers in training set
Top 3%
0.7%
28
Brain and Behavior
37 papers in training set
Top 2%
0.7%
29
Alzheimer's Research & Therapy
52 papers in training set
Top 2%
0.5%